Abbott (ABT) Tops Q4 EPS by 2c
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $106.86 -0.03%
EPS Growth %: -4.9%
Financial Fact:
Research and development: 352M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: -4.9%
Financial Fact:
Research and development: 352M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q4 EPS of $0.71, $0.02 better than the analyst estimate of $0.69. Revenue for the quarter came in at $5.36 billion versus the consensus estimate of $5.48 billion.
Abbott sees FY15 EPS of $2.10 - $2.20, with consensus estimates at $2.14.
The company sees Q1 EPS of $0.41 - $0.43, versus $0.41 expected.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Arca Biopharma (ABIO) Reports Q1 Loss of $0.14
- Byline Bancorp (BY) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
